Biocure Technology Inc (CURE)

CSE
0.0150
+0.0050(+50.00%)
  • Volume:
    3,000
  • Bid/Ask:
    0.0150/0.0200
  • Day's Range:
    0.0150 - 0.0150

CURE Overview

Prev. Close
0.01
Day's Range
0.015-0.015
Revenue
-
Open
0.015
52 wk Range
0.005-0.13
EPS
0.023
Volume
3,000
Market Cap
1.6M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
21,636
P/E Ratio
0.885
Beta
0.251
1-Year Change
-90%
Shares Outstanding
106,621,158
Next Earnings Date
-
What is your sentiment on Biocure Tech?
or
Market is currently closed. Voting is open during market hours.

Biocure Technology Inc Analysis

Biocure Technology Inc Company Profile

Biocure Technology Inc Company Profile

Employees
0
Market
Canada
  • Type:Equity
  • Market:Canada
  • ISIN:CA09075T1075
  • CUSIP:09075T107

Biocure Technology Inc., together with its subsidiary, engages in developing and commercializing biopharmaceutical technologies for use in recombinant and ranibizumab. The company is developing Interferons-ß for the treatment of multiple sclerosis; Ranibizumab, a monoclonal antibody fragment for the treatment of macular degeneration, as well as to treat a type of eye problem known as macular edema; and Filgrastim to treat neutropenia, a lack of white blood cells caused by cancer, bone marrow transplant, chemotherapy, or by other conditions. It also engages in the research and development of CAR T Cell therapy that identifies and destroys cancer cells; a foot and mouth disease vaccine; and hair growth products. The company was founded in 2005 and is headquartered in Vancouver, Canada.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellSellStrong Sell
Technical IndicatorsBuySellSellStrong SellStrong Sell
SummaryNeutralSellSellStrong SellStrong Sell